Cancel
MeiraGTx
See Linkedin
MeiraGTx Employees
10 people indexed:
-
u3z8fb9k@hnn51hd5.pf9 Sign up to see email
-
25832y2l9@j585zbj4.pll Sign up to see email
-
wqpuy199u@5036f60l.d4j Sign up to see email
-
s8yy4q@k6z467y5.y99 Sign up to see email
-
Richard Giroux
Chief Operating Officer and Chief Financial Officer
nns8y5b@sw1jsu07.7wp Sign up to see emailw4lw06j@1k0y4664.6ys Sign up to see email -
6f4kwh@608psyk2.kpu Sign up to see email
-
pq8w1v@s4wvp4ds.w44 Sign up to see email
-
d717wd@bbbjn3p0.h6z Sign up to see email
-
d21ulj@1u5wkvu3.4jb Sign up to see email
-
f53@39ylhp7z.k1d Sign up to see email
MeiraGTx Company Information
MeiraGTx operates as a biotechnology company dedicated to the development of gene therapies for patients with serious diseases. The company has a vertically integrated platform that includes end-to-end manufacturing capabilities, with facilities located in London, UK, and Shannon, Ireland, encompassing over 180,000 square feet. These facilities are equipped for various stages of production, including cell expansion, bulk production virus, downstream purification suites, fill and finish, and quality control laboratories. MeiraGTx focuses on inherited retinal diseases, neurodegenerative diseases, and severe forms of xerostomia. It currently runs six clinical programs and maintains a broad pipeline of preclinical and research programs. The company’s core capabilities lie in viral vector design and optimization, gene therapy manufacturing, and a gene regulation technology that uses synthetic riboswitches designed for mammalian cells. This technology allows for precise control of gene expression through proprietary oral small molecules. MeiraGTx has received several significant designations from regulatory agencies, including Fast Track, Orphan Drug, PRIME, and ATMP, for various programs. Additionally, it has formed strategic collaborations with notable companies like Janssen Pharmaceuticals to further the development and commercialization of its gene therapies.
Report inaccurate information
Report inaccurate information
